DelveInsight's Underactive Bladder Syndrome Market Insights report includes a comprehensive understanding of current ...

The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising prevalence of neurogenic and chronic conditions affecting bladder function.

West Tennessee Healthcare is pleased to announce a new treatment option for people living with urge urinary incontinence (UUI ...

With an estimated 12,600 new cases of bladder cancer in Canada in 2025, plus almost 84,870 in the United States, ranking 5th ...

The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...

The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...

Saudi Arabia's Food and Drug Authority grants conditional approval for Anktiva, a new cancer therapy for advanced lung and ...

Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...

Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...

Urology departments in England and Wales have seen an increase in bladder inflammation among 16 to 24-year-olds ...

Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational ...